Cleveland, Ohio—December 5, 2023— MIM Software Inc., a leading global provider of medical imaging software, announced US Food and Drug Administration (FDA) clearance of its newest AI auto-contouring solution, Contour ProtégéAI+™.
New Zero-Click AI Auto-Contouring Solution Gives Cancer Treatment Planners More Time for Plan Evaluation
- Contour ProtégéAI+ auto-contouring launches automatically when each patient is simulated. Clinicians don’t need to do anything to start the process.
- Head & neck and breast lymph node level structures are generated, along with OAR (organs at risk) structures.
- Auto-contours appear where they are needed for review—in the TPS or MIM®.
Unlike other auto-contouring tools, Contour ProtégéAI+ requires no clicks. Contouring of lymph node level and OAR structures starts automatically, and no manual intervention is required to launch. Results are exported directly to the TPS or MIM for review. This gives dosimetrists and physicians more time to create quality treatment plans for their patients.
“Cancer treatment planning teams should have as much time as possible to focus on developing precise, individualized treatment plans,” said Jay Obman, Product Manager at MIM Software Inc. “The MIM team is thrilled that zero-click auto-contouring of lymph node level and OAR structures with Contour ProtégéAI+ will save clinicians the time-consuming manual effort that comes with other auto-contouring tools.”
About MIM Software
MIM Software Inc. is headquartered in Cleveland, OH, with international offices in Beijing, Chengdu, and Brussels.
MIM Software sells its products globally to imaging centers, hospitals, specialty clinics, research organizations, and pharmaceutical companies. The company’s products are used in over 3,500 centers worldwide.
MIM Software is committed to enhancing patient care by providing customer-centered and innovative imaging solutions in the fields of Radiation Oncology, Radiology, Nuclear Medicine, Theranostics, Interventional Radiology, and Urology.
Media Contact
Bill Carruthers - Product Marketing Manager
Email: bcarruthers@mimsoftware.com
Phone: 216-455-0610
Written by MIM Software
GE HealthCare’s MIM Software is a global provider of medical imaging analysis and artificial intelligence (AI) solutions for the practice of Radiation Oncology, Radiology & Nuclear Medicine, Molecular Radiotherapy, Diagnostic Imaging, and Urology at imaging centers, hospitals, specialty clinics, and research organizations worldwide.
Read More
GE HealthCare’s MIM Software Announces FDA Clearance of Monte Carlo Dosimetry for Theranostics
Read the press release at gehealthcare.com.
GE HealthCare's MIM Software Announces FDA Clearance of New Centiloid Scaling Tool to Quantify Amyloid Plaque in Brain Imaging
Click Here to Read the Rest of the Press Release at gehealthcare.com
MIM Software Is a 2024 NorthCoast 99 Award Winner
Cleveland, Ohio—MIM Software has been named a2024 NorthCoast 99 award winner byERC, the Employers...
Send Me More Information 